LAZARD ASSET MANAGEMENT LLC - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 268 filers reported holding IMMUNOGEN INC in Q2 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.4%.

Quarter-by-quarter ownership
LAZARD ASSET MANAGEMENT LLC ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$307
+429.3%
19,406
+27.4%
0.00%
Q1 2023$58
-100.0%
15,232
-48.2%
0.00%
Q2 2022$132,000
+109.5%
29,389
+161.1%
0.00%
Q3 2021$63,000
+34.0%
11,256
+93.8%
0.00%
Q1 2021$47,000
-93.5%
5,807
-92.1%
0.00%
-100.0%
Q2 2018$718,000
-7.5%
73,8580.0%0.00%0.0%
Q1 2018$776,000
+108.6%
73,858
+27.2%
0.00%0.0%
Q4 2017$372,00058,0860.00%
Other shareholders
IMMUNOGEN INC shareholders Q2 2023
NameSharesValueWeighting ↓
QVT Financial LP 1,375,900$6,329,0001.08%
Redmile Group, LLC 12,006,979$55,232,0001.02%
Birchview Capital, LP 190,000$874,0000.53%
Fernwood Investment Management, LLC 179,340$825,0000.41%
HealthCor Management, L.P. 1,200,000$5,520,0000.23%
Grace Capital 49,500$228,0000.20%
TWIN FOCUS CAPITAL PARTNERS, LLC 104,068$479,0000.19%
Virtus ETF Advisers LLC 79,795$367,0000.17%
PINNACLE ASSOCIATES LTD 1,087,034$5,000,0000.12%
HUSSMAN STRATEGIC ADVISORS, INC. 100,000$460,0000.12%
View complete list of IMMUNOGEN INC shareholders